Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Pacientes con cáncer"'
Publikováno v:
Revista de Nutrición Clínica y Metabolismo, Vol 4, Iss 2 (2022)
El paciente con cáncer avanzado y en etapa terminal es susceptible de cuidados paliativos de calidad. Esto se lleva a cabo cuando el profesional paliativista tiene amplio conocimiento de todas las esferas implicadas, como son la física, la psicoló
Externí odkaz:
https://doaj.org/article/fb24f4841a9f4f99b5e7548b7cb3d1c4
Autor:
Abraham P. Buunk
Publikováno v:
Psicodebate, Vol 6, Iss 0, Pp 29-44 (2015)
Social comparison refers to relating one ́s own characteristics to those of other individuals. Due to the enhanced degree of physical distress, depression, and uncertainty, cancer patients tend to compare themselves often with other patients, especi
Externí odkaz:
https://doaj.org/article/b87b71f064a145dba3902451d8935a00
Autor:
Catalina Falo Zamora, Helena Villar Abelló, Eva Rodríguez Bruzos, Marisa Mena Cervignon, Antoni Font Guiteras
Publikováno v:
Psicooncologia, Vol 11, Iss 2-3, Pp 313-331 (2014)
Metastasic breast cancer patients live longer thanks to the lasts improvements in their treatment. Nonetheless, there exist few studies focused on the quality of live (QoL) of those patients. The aim of our study is to improve the knowledge of metast
Externí odkaz:
https://doaj.org/article/2aa07ce5cd854560ab23de5c3f4dc2b8
Publikováno v:
Brazilian Journal of Obesity, Nutrition and Weight Loss; Vol. 15 No. 96 (2021); 861-870
Revista Brasileña de Obesidad, Nutrición y Pérdida de Peso; Vol. 15 Núm. 96 (2021); 861-870
Giornale brasiliano di obesità, nutrizione e perdita di peso; V. 15 N. 96 (2021); 861-870
RBONE-Revista Brasileira de Obesidade, Nutrição e Emagrecimento; v. 15 n. 96 (2021); 861-870
Revista Brasileira de Obesidade, Nutrição e Emagrecimento; v. 15 n. 96 (2021); 861-870
Revista brasileira de obesidade, nutrição e emagrecimento
Instituto Brasileiro de Ensino e Pesquisa em Fisiologia do Exercício (IBPEFEX)
instacron:IBPEFEX
Revista Brasileña de Obesidad, Nutrición y Pérdida de Peso; Vol. 15 Núm. 96 (2021); 861-870
Giornale brasiliano di obesità, nutrizione e perdita di peso; V. 15 N. 96 (2021); 861-870
RBONE-Revista Brasileira de Obesidade, Nutrição e Emagrecimento; v. 15 n. 96 (2021); 861-870
Revista Brasileira de Obesidade, Nutrição e Emagrecimento; v. 15 n. 96 (2021); 861-870
Revista brasileira de obesidade, nutrição e emagrecimento
Instituto Brasileiro de Ensino e Pesquisa em Fisiologia do Exercício (IBPEFEX)
instacron:IBPEFEX
O câncer promove diversas alterações fisiológicas, psíquicas, mentais e sociais na vida do paciente. Durante o tratamento oncológico, é comum a ocorrência da redução do apetite, dificuldades mecânicas na deglutição dos alimentos, além d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::01859fa71c41a6203efcc0ee226df13f
http://www.rbone.com.br/index.php/rbone/article/view/1839
http://www.rbone.com.br/index.php/rbone/article/view/1839
Autor:
Oscar Galindo Vázquez, Mayelli Muñóz Martínez, Sofía Campos Ugalde, Edith Rojas Castillo, María Cristina Maya Vázquez, Salvador Alvarado Aguilar
Publikováno v:
Psicooncologia, Vol 10, Iss 2-3, Pp 407-415 (2014)
Objective: Develop and validate a Checklist of psycho-oncologic issues (LC-Psycho-onco) for oncologic patients in treatment. Method: We included 200 patients at the National Cancer Institute (INCAN). The sample collection was for availability during
Externí odkaz:
https://doaj.org/article/a08288e9d77f4fd881e6cfd9f6984677
Autor:
Costa, Jardel Alves da, Ricardo , Nayara Ferreira, Fontinele , Renata Rodrigues Costa, Barros, Gabrielly Martins de, Damasceno, Dênaba Luyla Lago, Pereira , Ana Rafaela Silva, Lima, Diêgo de Oliveira, Souza, Fernanda Lopes, Silva, Ronnyely Suerda Cunha, Silva, Janaina Morais da, Sousa, Mycaele Aline Santana, Carneiro, Cláudia Resende, Gonçalves, Cleyde Regina Carvalho de Sousa, Silva, Lilian Carvalho da, Martins, Sâmia Karine de Moura, Silva, Clécia Maria da, Mendes , Taynara de Sousa Rego
Publikováno v:
Research, Society and Development; Vol. 10 No. 17; e234101724196
Research, Society and Development; Vol. 10 Núm. 17; e234101724196
Research, Society and Development; v. 10 n. 17; e234101724196
Research, Society and Development
Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
Research, Society and Development; Vol. 10 Núm. 17; e234101724196
Research, Society and Development; v. 10 n. 17; e234101724196
Research, Society and Development
Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
The research aims to carry out a literature review on studies that applied nutritional conducts in enteral nutrition in clinical practice for the treatment of cancer patients and report the benefits of this type of therapy. This is an integrative lit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::adeec9ef84e09358c4938c37cb19d23a
https://rsdjournal.org/index.php/rsd/article/view/24196
https://rsdjournal.org/index.php/rsd/article/view/24196
Publikováno v:
Psicooncologia, Vol 7, Iss 2, Pp 363-374 (2010)
Objective: The aim of the study is to explore if cancer patients actively participate in their care and are involved in treatment decisions. Method: 4 focus groups were organized for a total of 29 participants. One group with patients older than 63 y
Externí odkaz:
https://doaj.org/article/71996214df414f4e8d275a0dee36260e
Publikováno v:
Chang C, Chien W, Chung C, Lee J, Hsu S, Chen J. Impact of hemodialysis on the prognosis of multiple myeloma: A nationwide population-based study and single-institute analysis. Oncology Letters. 2018
Berni Wennekers A, Martín Azara M, Dourdil Sahun V, Bergasa Liberal B, Ruiz Laiglesia J, Vernet Perna P et al. Trece tratamientos de la insuficiencia renal aguda secundaria a mieloma múltiple con filtros de high cut off. Nefrología. 2016.
Wirk B. Renal failure in multiple myeloma: a medical emergency. Bone Marrow Transplantation. 2011
Yadav P, Hutchison C, Basnayake K, Stringer S, Jesky M, Fifer L et al. Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysisdependent acute kidney injury. European Journal of Haematology. 2015.
Tsakiris DJ, Stel VS, Finne P, Fraser E, Heaf J, de Meester J, et al. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrology Dialysis Transplantation. 1 de abril de 2010
Hutchison C, Batuman V, Behrens J, Bridoux F, Sirac C, Dispenzieri A et al. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nature Reviews Nephrology. 2011.
Favà A, Fulladosa X, Montero N, Draibe J, Torras J, Gomà M, et al. Treatment of multiple myeloma with renal involvement: the nephrologist’s view. Clinical Kidney Journal. 1 de diciembre de 2018
Leung N, Behrens J. Current Approach to Diagnosis and Management of Acute Renal Failure in Myeloma Patients. Advances in Chronic Kidney Disease. septiembre de 2012
Haynes RJ, Read S, Collins GP, Darby SC, Winearls CG. Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre. Nephrology Dialysis Transplantation. 1 de febrero de 2010
Decourt A, Gondouin B, Delaroziere J, Brunet P, Sallée M, Burtey S et al. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis. Clinical Journal of the American Society of Nephrology. 2016
Korbet S. Multiple Myeloma. Journal of the American Society of Nephrology. 2006
Tapson JS, Mansy H, Wilkinson R. End-stage renal failure due to multiple myelomapoor survival on peritoneal dialysis. Int J Artif . Organs 1988; 11: 39–42
Pozzi C, D'Amico M, Fogazzi GB et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 2003
Goldschmidt H, Lannert H, Bommer J et al. Multiple myeloma and renal failure. Nephrol Dial Transplant 2000
Batuman V, et al. Myeloma light chains are ligands for cubilin (gp280). Am. J. Physiol. 1998
Klassen RB, Allen PL, Batuman V, Crenshaw K, Hammond TG. Light chains are a ligand for megalin. J. Appl. Physiol. 2005.
Li M, Hering-Smith KS, Simon EE, Batuman V. Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol. Dial. Transplant. 2008
Pote A, Zwizinski C, Simon EE, Meleg-Smith S, Batuman V. Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells. Am. J. Kidney Dis. 2000
Sengul S, Zwizinski C, Batuman V. Role of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells. Am. J. Physiol. Renal Physiol. 2003
Sengul S, et al. Endocytosis of light chains induces cytokines through activation of NF-κB in human proximal tubule cells. Kidney Int. 2002
Sanders PW, Herrera GA, Kirk KA, Old CW, Galla JH. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab. Invest. 1991
Drayson M, et al. Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventionaldose chemotherapy in Medical Research Council UK multiple myeloma trials. Blood. 2006
Terpos E, Roodman E, Dimopoulus M. Optimal use of bisphosphonates in patients with multiple myeloma. BLOOD, 25. April 2013
Copyright and License Information. Section 5: dialysis interventions for treatment of AKI. Kidney Int Suppl (2011). Nature, 2012
Ahmad M. Continuous ambulatory peritoneal dialysis in patients with renal failure due to multiple myeloma. International Urology and Nephrology. 2007
Cook M, Hutchison C, Fifer L, Gillmore J, Heyne N, Weisel K et al. High cut-off haemodialysis (HCO-HD) does not improve outcomes in myeloma cast nephropathy: results of European trial of Free Light Chain removal extended haemodialysis in cast nephropathy (EULITE). EHA Learning Center. Cook M. Jun. 2016
Dimopoulos MA, Roussou M, Gavriatopoulou M, et al. Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit. Blood Cancer J. 2017
Sakhuja V, Jha V, Varma S, Joshi K, Gupta K, Sud K et al. Renal involvement in multiple myeloma: a 10-year study. Renal Failure. 2000.
Blade L, Fernández-Llama R, Bosch E, Montoliu J, Lens W, Montoto S, Cases A, Darnell A, Rozman C, Montserrat E: Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med. 1998
Reyes M, Valera A, Frutos A, Ramos B, Ordoñez V, Lopez De Novales E. Supervivencia de pacientes con mieloma tratados con diálisis. Nefrología. 2003
Hsu C, Ordoñez J, Chertow G, Fan D, McCulloch C, Go A. The risk of acute renal failure in patients with chronic kidney disease. Kidney International. 2008
Hutchison C, Bradwell A, Cook M, Basnayake K, Basu S, Harding S et al. Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis. Clinical Journal of the American Society of Nephrology. 2009
Bridoux F, Carron P, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A et al. Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy. JAMA. 2017
Antlanger M, Dust T, Reiter T, Böhm A, Lamm W, Gornicec M et al. Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study. BMC Cancer. 2018
Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Berni Wennekers A, Martín Azara M, Dourdil Sahun V, Bergasa Liberal B, Ruiz Laiglesia J, Vernet Perna P et al. Trece tratamientos de la insuficiencia renal aguda secundaria a mieloma múltiple con filtros de high cut off. Nefrología. 2016.
Wirk B. Renal failure in multiple myeloma: a medical emergency. Bone Marrow Transplantation. 2011
Yadav P, Hutchison C, Basnayake K, Stringer S, Jesky M, Fifer L et al. Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysisdependent acute kidney injury. European Journal of Haematology. 2015.
Tsakiris DJ, Stel VS, Finne P, Fraser E, Heaf J, de Meester J, et al. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrology Dialysis Transplantation. 1 de abril de 2010
Hutchison C, Batuman V, Behrens J, Bridoux F, Sirac C, Dispenzieri A et al. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nature Reviews Nephrology. 2011.
Favà A, Fulladosa X, Montero N, Draibe J, Torras J, Gomà M, et al. Treatment of multiple myeloma with renal involvement: the nephrologist’s view. Clinical Kidney Journal. 1 de diciembre de 2018
Leung N, Behrens J. Current Approach to Diagnosis and Management of Acute Renal Failure in Myeloma Patients. Advances in Chronic Kidney Disease. septiembre de 2012
Haynes RJ, Read S, Collins GP, Darby SC, Winearls CG. Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre. Nephrology Dialysis Transplantation. 1 de febrero de 2010
Decourt A, Gondouin B, Delaroziere J, Brunet P, Sallée M, Burtey S et al. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis. Clinical Journal of the American Society of Nephrology. 2016
Korbet S. Multiple Myeloma. Journal of the American Society of Nephrology. 2006
Tapson JS, Mansy H, Wilkinson R. End-stage renal failure due to multiple myelomapoor survival on peritoneal dialysis. Int J Artif . Organs 1988; 11: 39–42
Pozzi C, D'Amico M, Fogazzi GB et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 2003
Goldschmidt H, Lannert H, Bommer J et al. Multiple myeloma and renal failure. Nephrol Dial Transplant 2000
Batuman V, et al. Myeloma light chains are ligands for cubilin (gp280). Am. J. Physiol. 1998
Klassen RB, Allen PL, Batuman V, Crenshaw K, Hammond TG. Light chains are a ligand for megalin. J. Appl. Physiol. 2005.
Li M, Hering-Smith KS, Simon EE, Batuman V. Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol. Dial. Transplant. 2008
Pote A, Zwizinski C, Simon EE, Meleg-Smith S, Batuman V. Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells. Am. J. Kidney Dis. 2000
Sengul S, Zwizinski C, Batuman V. Role of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells. Am. J. Physiol. Renal Physiol. 2003
Sengul S, et al. Endocytosis of light chains induces cytokines through activation of NF-κB in human proximal tubule cells. Kidney Int. 2002
Sanders PW, Herrera GA, Kirk KA, Old CW, Galla JH. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab. Invest. 1991
Drayson M, et al. Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventionaldose chemotherapy in Medical Research Council UK multiple myeloma trials. Blood. 2006
Terpos E, Roodman E, Dimopoulus M. Optimal use of bisphosphonates in patients with multiple myeloma. BLOOD, 25. April 2013
Copyright and License Information. Section 5: dialysis interventions for treatment of AKI. Kidney Int Suppl (2011). Nature, 2012
Ahmad M. Continuous ambulatory peritoneal dialysis in patients with renal failure due to multiple myeloma. International Urology and Nephrology. 2007
Cook M, Hutchison C, Fifer L, Gillmore J, Heyne N, Weisel K et al. High cut-off haemodialysis (HCO-HD) does not improve outcomes in myeloma cast nephropathy: results of European trial of Free Light Chain removal extended haemodialysis in cast nephropathy (EULITE). EHA Learning Center. Cook M. Jun. 2016
Dimopoulos MA, Roussou M, Gavriatopoulou M, et al. Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit. Blood Cancer J. 2017
Sakhuja V, Jha V, Varma S, Joshi K, Gupta K, Sud K et al. Renal involvement in multiple myeloma: a 10-year study. Renal Failure. 2000.
Blade L, Fernández-Llama R, Bosch E, Montoliu J, Lens W, Montoto S, Cases A, Darnell A, Rozman C, Montserrat E: Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med. 1998
Reyes M, Valera A, Frutos A, Ramos B, Ordoñez V, Lopez De Novales E. Supervivencia de pacientes con mieloma tratados con diálisis. Nefrología. 2003
Hsu C, Ordoñez J, Chertow G, Fan D, McCulloch C, Go A. The risk of acute renal failure in patients with chronic kidney disease. Kidney International. 2008
Hutchison C, Bradwell A, Cook M, Basnayake K, Basu S, Harding S et al. Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis. Clinical Journal of the American Society of Nephrology. 2009
Bridoux F, Carron P, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A et al. Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy. JAMA. 2017
Antlanger M, Dust T, Reiter T, Böhm A, Lamm W, Gornicec M et al. Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study. BMC Cancer. 2018
Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: Hasta el 50% de los pacientes con mieloma múltiple de nuevo diagnóstico presentan una lesión renal aguda secundaria a la neoplasia, que se produce por eventos multifactoriales, siendo la lesión tubular por precipitación y la toxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e80acb9da75e5401b931245e48e0e6
https://repository.urosario.edu.co/handle/10336/32211
https://repository.urosario.edu.co/handle/10336/32211
Autor:
Andrea Rodríguez-Prat, Denise Pergolizzi, Iris Crespo, Albert Balaguer, Josep Porta-Sales, Cristina Monforte-Royo
Publikováno v:
BMC palliative care. 21(1)
Background In the context of life-threatening illness, loss of control is argued as a source of suffering and loss of perceived dignity, whereas having control over the dying process has been seen as a way of maintaining personal independence. Little
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a63ba4d412b5d9ed02c8a6f0c488a35
https://pubmed.ncbi.nlm.nih.gov/35650600
https://pubmed.ncbi.nlm.nih.gov/35650600